Paraoxanase as an indicator of myocardial ischemia and its utility in determining extension of ischemia
- 1 January 2016
- journal article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 34 (1) , 45-48
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Paraoxonase 1 and HDL maturationClinica Chimica Acta, 2015
- HDL anti-oxidant function associates with LDL level in young adultsAtherosclerosis, 2014
- Paraoxonases2013
- Antiinflammatory Properties of HDLCirculation Research, 2004
- Pharmacogenetics of paraoxonases: a brief reviewNaunyn-Schmiedeberg's Archives of Pharmacology, 2004
- Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequenceGene, 1998
- The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene FamilyGenomics, 1996
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983